Good Blood Management: The Effective and Safe use of Blood Components

Practical Transfusion Medicine: Third Edition

Volumn , Issue , 2009, Pages 263-284

  Mcclelland, Brian ^a   Walsh, Tim ^b  

^a SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Allogeneic blood; Chronic anaemia; Cryoprecipitate; Haemolytic uraemic syndrome (HUS); Parenteral iron administration; Perioperative red cell transfusion; Pre admission clinic; Thrombocytopenia; Transplant of human tissue

Indexed keywords

EID: 84890253044     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444311761.ch25     Document Type: Chapter

References (22)

1. www.learnbloodtransfusion.org.uk. E learning programmes for safe blood transfusion, information about blood components etc. Accessed at January 2009.
2. www.transfusionguidelines.org.uk. Free access to UK Handbook of Transfusion Medicine, 4th edn 2007, Better Blood Transfusion Toolkit, UK standards for blood components. Links to BCSH Guidelines, Cochrane library etc. Accessed at January 2009.
3. Carless PA, Henry DA, Moxey AJ, O'Connell DL, Brown T & Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2006;(4):CD001888.
4. Carson JL, Hill S, Carless P, Hebert P & Henry D. Transfusion triggers: a systematic review of the literature. Transfus Med Rev 2002;16:187-199.
5. Hill SR, Carless PA, Henry DA et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2000;(1):CD002042.
6. Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB & Murphy MF. Is fresh frozen plasma clinically effective? A systematic review of randomised controlled trials. Br J Haematol 2004;126:139-152.
7. Stanworth SJ, Brunskill SJ, Hyde CJ, Murphy MF & Mc- Clelland DBL. Appraisal of the evidence for the clinical use of FFP and plasma fractions. Best Pract Res Clin Haematol 2006;19:67-82.
8. Stanworth SJ, Hyde C, Brunskill S & Murphy M. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now? Br J Haematol 2005;131:588-595.
9. Stanworth SJ, Hyde C, Heddle N, Rebulla P, Brunskill S & Murphy MF. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev 2004; (4):CD004269.
10. Wilson J, Yao GL, Raftery J et al. A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment. Health Technol Assess 2007;11:1-220.
11. Auroy Y, Lienhart A, Péquignot F & Benhamou D. Complications related to blood transfusion in surgical patients: data from the French national survey on anesthesia-related deaths. Transfusion 2007;47(Suppl 2):184S-189S.
12. Carson JL, Terrin ML, Magaziner J et al., FOCUS Investigators. Transfusion trigger trial for functional outcomes in cardiovascular patients undergoing surgical hip fracture repair (FOCUS). Transfusion 2006;46:2192-2206.
13. Finfer S, Bellomo R, Boyce N, French J,Myburgh J & Norton R, SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-2256.
14. Hébert PC, Wells G, Blajchman MA et al. With the Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. A multicentre, randomized controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409-417.
15. Kirpalani H, Whyte RK, Andersen C et al. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr 2006;149:301-307.
16. Lienhart A, Auroy Y, Pequignot F et al. Survey of anesthesia-related mortality in France. Anesthesiology 2006;105:1087-1097.
17. Mangano DT, Miao Y, Vuylsteke A et al. Investigators of The Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007;297:471-479.
18. McLellan SA, Walsh TS & McClelland DBL. Should we demand fresh red blood cells for perioperative and critically ill patients? Br J Anaesth 2002;89:537-540. (Editorial)
19. Rao SV, Jollis JG, Harrington RA et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004;292:1555-1562.
20. Sanguis Study Group. Use of blood products for elective surgery in 43 European hospitals. Transfus Med 1994;4:251-268.
21. Walsh TS, McArdle F, McLellan SA et al. Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients? Crit Care Med 2004;32:364-371.
22. Weiskopf RB, Feiner J, Hopf H et al. Fresh blood and aged stored blood are equally efficacious in immediately reversing anemia-induced brain oxygenation deficits in humans. Anesthesiology 2006;104:911-920.